PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
17699726-10	2007	Inhibition of DPD activity by CDHP may enhance the efficacy of IFN-alpha and 5-FU combination therapy in patients with HCC showing resistance to this therapy.	gimeracil	30-34	interferon alpha 1	Homo sapiens	63-72	
17699726-7	2007	Coadministration of a selective DPD inhibitor, 5-chloro-2,4-dihydroxypyridine (CDHP), enhanced the antiproliferative effect of 5-FU and IFN-alpha on KYN-3 approximately 4-fold.	gimeracil	47-77	interferon alpha 1	Homo sapiens	136-145	
17699726-7	2007	Coadministration of a selective DPD inhibitor, 5-chloro-2,4-dihydroxypyridine (CDHP), enhanced the antiproliferative effect of 5-FU and IFN-alpha on KYN-3 approximately 4-fold.	gimeracil	79-83	interferon alpha 1	Homo sapiens	136-145